Founding Members Look to Provide Operators with Best Practices and Equipment in Raw Material Manufacturing. Global Allied Processing Solutions (“G-APS” or “Organization”) today announced its strategic focus on the global organic material industry through its recent formation of an alliance representing companies on the forefront of technological advancements in processing equipment and practices. Founding members RotaChrom […]
SAN DIEGO & CAMBRIDGE, MASS. – Biosero, Inc. and Elemental Machines will integrate Biosero’s Green Button Go™ Automation Scheduling Software with Elemental Machines’ AI-powered platform so scientists and researchers can produce consistent, reliable results from every life science laboratory experiment. Biosero’s device- and data-agnostic laboratory automation software will integrate with the Elemental Machines intelligent IoT platform to connect it […]
Amsterdam, the Netherlands — In their quest of creating safe and effective immunotherapy cancer treatments, LUMICKS and LAVA Therapeutics joined forces. The partnership aims to evaluate the efficacy of various tumor-specific γδ T-cell engagers based on the resulting binding strengths (cell avidity) between T cells and tumors, measured with LUMICKS newly installed z-Movi® Cell Avidity Analyzer. LAVA Therapeutics […]
GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology company, a spin-off from South Korean biotech company Tiumbio, seeking antibody-based therapeutics for patients who are suffering from unaddressed incurable and rare diseases. The strategic collaboration […]
– Supporting drug development research through the use of HCA and three-dimensional culture models – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has entered into a partnership agreement with InSphero AG, a pioneer in the development of 3D in vitro*1 technologies for drug discovery and safety. The two companies aim to establish […]
Simplify drug efficacy and neurotoxicity evaluation TOKYO, Japan – Ricoh Co., Ltd. (Tokyo, Japan) and Elixirgen Scientific, Inc. (Baltimore, Maryland, USA) have jointly developed assay-ready cell plates, which may dramatically simplify the drug efficacy testing for neurological diseases and the neurotoxicity testing for chemical compounds. This product contains human neurons generated from human induced pluripotent stem […]
Positioning Australia at the forefront of healthcare innovation The Victorian Government collaborated with the University of Melbourne and Illumina to secure a $60 million investment for a world-leading genomics hub in Victoria called the Illumina–University of Melbourne Genomics Hub. This collaboration puts Victoria, the University of Melbourne’s researchers, students, and precinct partners at the forefront […]
Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research CAMBRIDGE, and MACCLESFIELD, UK – The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, today announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency. Optibrium […]
Associated Collaboration with the New York Genome Center to Expand Patient Access to Advanced Genomic Technologies New York — Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has utilized two Bio-Techne branded product lines, ProteinSimple and Exosome Diagnostics, to aid in their clinical trial patient testing. RGLS4326 […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
